Daily as of 3 Nov 16:00 ET
- Price
- above both $118.60 vs 50 $112.68 / 200 $108.05
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 9 Oct 2025 ยท projected 10 bars out
VanEck Pharmaceutical ETF (PPH) is a NASDAQ-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Jun 2026 | ๐จGolden | 4-hour | 24 bars out | Not tested |
| 7 Apr 2026 | ๐Death | 4-hour | 27 bars out | 5 bar cross test |
| 9 Oct 2025 | ๐จGolden moderate | daily | 10 bars out | Not tested |
| 10 Sep 2025 | ๐จGolden | 4-hour | 20 bars out | โ |
| 18 Jul 2025 | ๐Death | 4-hour | 7 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.